The investigational hepatitis C virus (HCV) protease inhibitor telaprevir [VX 950] appears to be effective and well tolerated

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1569, 2007-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 3-16

Bentham Science Publishers

Access to resources Recommend Favorite

Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

By  

Current Medicinal Chemistry, Vol. 16, Iss. 9, 2009-03 ,pp. : 1115-1121

Bentham Science Publishers

Access to resources Recommend Favorite

Rosuvastatin is effective and well tolerated in the treatment of protease inhibitor-induced hyperlipidaemia

By  

Reactions Weekly, Vol. 1, Iss. 1062, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Computational Modelling in Studies for Hepatitis C Virus (HCV) NS3 Protease

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 12, 2016-03 ,pp. : 1351-1361

Bentham Science Publishers

Access to resources Recommend Favorite

Topical ciclopirox is well tolerated and appears to be as effective as topical ketoconazole

By  

Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite